ONCO Onconetix, Inc.
$0.40▼ -4.52%
Healthcare
Other
Pre-market
$0.34▼ -14.83%
Oct 27, 7:54 AM ET
Volume 449.1K
Avg Volume (10D) 466.9K
Key Metrics & Fundamentals
Market Cap
$2.09M
P/E Ratio
0.0
Div Yield
0.00%
52W Range
0.38 - 200.00
% vs 50 MA
-40.73%
% vs 200 MA
-97.42%
RSI-14
32.7
MACD Histogram
-0.0200
Beta (1Y vs SPY)
0.93
Free Cash Flow
-$1.92M
Gross Rev
$17,120
Gross Profit
$4,303
EBITDA
-$2.24M
COGS
$12,817
Operating Exp
$2.25M
Operating Income
-$2.24M
EBIT
-$2.24M
Pretax Income
-$2.87M
Net Income
-$2.87M
EPS (Diluted)
-1.28
Price & Volume History
Loading chart…
Recent News
Onconetix Acquisition Target Realbotix Launches Echo Humanoid Robot Line with Tabletop and Full Body Models Designed for Education, Wellness, and Social Engagement
GlobeNewswire · Oct 27, 2026 8:30 AM ET
Onconetix Announces Reverse Stock Split
GlobeNewswire · Oct 26, 2026 5:03 PM ET
Onconetix Provides Additional Strategic Bridge Financing to Realbotix LLC in Continued Support of Pending Acquisition
GlobeNewswire · Oct 23, 2026 8:30 AM ET
Realbotix Announces Additional Draw under Bridge Loan from Onconetix
Business Wire · Oct 23, 2026 7:30 AM ET
BC-Most Active Stocks
Associated Press · Oct 8, 2026 10:30 AM ET
BC-Most Active Stocks
Associated Press · Sep 25, 2026 10:30 AM ET
SRX Global Makes Investment in Onconetix
MT Newswires · Sep 24, 2026 1:14 PM ET
SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)
GlobeNewswire · Sep 24, 2026 12:30 PM ET
CORRECTED: Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition
GlobeNewswire · Sep 14, 2026 12:50 PM ET
Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition
GlobeNewswire · Sep 14, 2026 8:30 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See ONCO's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.